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In Brief
Seiler et al. investigate exercise fatigue
due tometabolic inertia and show that the
nutritionally regulated enzyme carnitine
acetyltransferase (CrAT), which
interconverts acetyl-CoA and
acetylcarnitine, plays a key role in
modulating muscle energy economy.
CrAT modulation could prove a useful
strategy in delaying muscle fatigue and
combatting exercise intolerance.
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Acylcarnitine metabolites have gained attention
as biomarkers of nutrient stress, but their physiolog-
ical relevance and metabolic purpose remain
poorly understood. Short-chain carnitine conjugates,
including acetylcarnitine, derive from their corre-
sponding acyl-CoA precursors via the action of
carnitine acetyltransferase (CrAT), a bidirectional
mitochondrial matrix enzyme. We show here that
contractile activity reverses acetylcarnitine flux in
muscle, from net production and efflux at rest to net
uptake and consumption during exercise. Disruption
of this switch in mice with muscle-specific CrAT defi-
ciency resulted in acetyl-CoA deficit, perturbed
energy charge, and diminished exercise tolerance,
whereas acetylcarnitine supplementation produced
opposite outcomes in a CrAT-dependent manner.
Likewise, in exercise-trained compared to untrained
humans, post-exercise phosphocreatine recovery
rates were positively associated with CrAT activity
and coincided with dramatic shifts in muscle acetyl-
carnitine dynamics. These findings show acetylcarni-
tine serves as a critical acetyl buffer for workingmus-
cles and provide insight into potential therapeutic
strategies for combatting exercise intolerance.
INTRODUCTION
Habitual exercise not only improves physical fitness and muscle
strength, but also promotes metabolic health and mitigates a
wide range of medical conditions (Pattyn et al., 2013). Impor-
tantly however, aging and other chronic disorders are often
accompanied by exercise intolerance, leading to a vicious cycle
of inactivity and accelerated cardiometabolic decay. In light of an
aging population and the growing worldwide prevalence ofmetabolic disease, efforts to understand and modify exercise
fatigue have become increasingly relevant to global health.
At the most fundamental level, exercise tolerance depends on
the ability of working muscles to resynthesize ATP at a rate that
matches the costs of contractile activity. Sustained regeneration
of ATP is driven principally by mitochondrial oxidative phosphor-
ylation (OXPHOS), a less powerful but more efficient and higher
capacity system than glycolysis. Whereas muscle mitochondrial
content and respiratory potential are well-recognized determi-
nants of exercise tolerance, several studies have shown that per-
formance during both short- and long-term activities can also be
influenced by the degree to which rates of OXPHOS lag during
the first several minutes of exercise and/or during stepwise
increments in workload before achieving a new steady-state (re-
viewed in Poole and Jones, 2012). This slow component of oxy-
gen uptake kinetics in response to increasing power output is
thought to reflect metabolic capacitance conferred by the crea-
tine energy transfer system and has been linked to metabolic
instability and muscle contractile inefficiency (Poole and Jones,
2012).
Rapid adjustments in the rate of OXPHOS depend on shifts in
muscle energy charge, availability of oxygen as the final electron
acceptor, and a steady supply of electron donors, in the form of
NADH and FADH2, to fuel the electron transport chain (ETC). His-
torically, two general theories have been investigated to account
for the foregoing lag in whole-body oxygen consumption during
abrupt increases in work rate. The first centers on potential lim-
itations at the level of bulk oxygen delivery to working muscles,
whereas an alternative explanation proposes intramuscular
processes involving delayed enzyme activation and carbon flux
through oxidative metabolic machinery, known as metabolic
inertia (Greenhaff et al., 2002; Murias et al., 2014; Poole and
Jones, 2012). Whereas limitations in oxygen delivery have
been identified under some circumstances (Murias et al., 2014;
Raper et al., 2014), considerable evidence suggests a more
prominent role for metabolic inertia (Poole and Jones, 2012).
Among potential factors contributing to sluggish ramping of
oxidative metabolism is a deficit in acetyl group availability
(Greenhaff et al., 2002). Acetyl-CoA holds a prominent positionCell Metabolism 22, 65–76, July 7, 2015 ª2015 Elsevier Inc. 65
in exercise bioenergetics as the universal two-carbon intermedi-
ate of glucose, fatty acid, and amino acid catabolism. Because
acetyl-CoA fuels the tricarboxylic acid cycle (TCAC), which in
turn provides reducing power for OXPHOS, a deficit in acetyl-
CoA supply would be predicted to limit the rate of oxidative
ATP production.
The metabolic inertia theory draws attention to nutritional and
pharmacological maneuvers that might augment the provision of
specific acetyl group precursors (Raper et al., 2014). Relevant to
this idea is emergent evidence that mitochondrial acetyl-CoA
balance can be nutritionally regulated via the carnitine-depen-
dent enzyme, carnitine acetyltransferase (CrAT) (Muoio et al.,
2012). This enzyme, which is highly enriched in muscle and heart
(Noland et al., 2009) and localized to the mitochondrial matrix,
converts short-chain acyl-CoAs to their membrane permeant
acylcarnitine counterparts, thereby permitting intracellular traf-
ficking of acyl moieties. Results from loss- and gain-of-function
studies show that CrAT-mediated acetylcarnitine production
and efflux promotes glucose homeostasis and alleviates product
inhibition of pyruvate dehydrogenase (PDH), the mitochondrial
enzyme complex that connects glycolysis to glucose oxidation
(Muoio et al., 2012; Noland et al., 2009). Moreover, dietary sup-
plementation with L-carnitine increased tissue acetylcarnitine
efflux and enhanced glucose tolerance and oxidation when
administered to obese rodents and humans (Muoio et al.,
2012; Noland et al., 2009). These findings raised the question
of why muscle tissues express such high amounts of an enzyme
that essentially siphons acetyl-CoA from the TCA cycle. The
answer probably relates to the freely reversible nature of CrAT,
which interconverts acetyl-CoA and acetylcarnitine with an equi-
librium constant of1.5 (Pieklik and Guynn, 1975). Thus, CrAT is
positioned to play a key role in buffering the mitochondrial acetyl
group pool during transitions from low to high energy demand,
and vice versa.
Short-chain acylcarnitines are present in tissues and blood
and have gained increasing attention as biomarkers of metabolic
stress. Although previous studies have reported that intramus-
cular and circulating levels of acetylcarnitine increase during
and/or immediately after exercise (Hiatt et al., 1989; Putman
et al., 1993; Sahlin, 1990), it is still unclear whether these metab-
olites are dispensable metabolic byproducts or, alternatively, if
they serve an important physiologic purpose. Herein, we sought
to determine whether acetylcarnitine metabolism is required for
optimal exercise performance. To this end, we examined the
impact of skeletal-muscle-specific CrAT deficiency on muscle
bioenergetics, acetyl group balance, and exercise stamina.
Our findings not only establish important roles for CrAT and
acetylcarnitine in modulating muscle energy economy during
contraction but also suggest that nutritional and/or pharmaco-
logical strategies aimed at promoting CrAT activity could prove
useful for offsetting metabolic inertia, delaying muscle fatigue,
and combatting exercise intolerance.
RESULTS AND DISCUSSION
CrAT Fiber Type Distribution and Regulation by Exercise
To characterize the relationship between CrAT and muscle func-
tion, we examined enzyme abundance in different muscle types
as well as its regulation in response to exercise. In general, CrAT66 Cell Metabolism 22, 65–76, July 7, 2015 ª2015 Elsevier Inc.protein abundance was highest in the most oxidative/red mus-
cles as compared to those comprised of a more glycolytic/white
fiber types (Figures 1A and S1). This expression pattern was only
partly attributable to total mitochondrial content, as CrAT abun-
dancewas also dissimilar among isolatedmitochondria prepara-
tions harvested from different rat muscles (Figures 1B and S1).
Mitochondrial abundance of CrAT tracked most closely with
muscle enrichment of type IIa (intermediate) myofibers. Skeletal
muscle mRNA levels of Crat increased 4-fold in response to an
acute 90 min mid-intensity exercise bout (Figure 1C). This was
evident immediately and up to 24 hr after exercise as compared
to the rested controls and was accompanied by upregulation
of the exercise-inducible transcriptional co-activator, Pgc1a
(Koves et al., 2013). Likewise, muscles from MCK-Pgc1a trans-
genic mice had increased Crat gene expression (Figure 1D), and
adenoviral-mediated overexpression of mPgc1a in primary
human skeletal myocytes grown in culture produced a similar
stimulatory effect (Figure 1E), suggesting a role for this enzyme
in exercise adaptation. We next used a tissue incubation bath
system coupled with mass-spectrometry-based [13C]glucose
tracer methodology to estimate contraction-induced changes
in net acetylcarnitine flux in isolated soleus muscles. Notably,
electrical stimulation appeared to reverse acetylcarnitine flux,
promoting net muscle uptake of the metabolite, whereas the re-
covery period was characterized by elevated rates of efflux as
compared to either the contracted or rested states (Figure 1F).
In aggregate, these results implied a key role for CrAT in main-
taining mitochondrial acetyl group balance during and immedi-
ately after exercise.
Skeletal-Muscle-Specific Loss of CrAT Compromised
Exercise Performance despite Increased Fat Oxidation
To further explore the functional importance of CrAT during exer-
cise, we used the Lox-P/Cre system to generate mice lacking
Crat specifically in skeletal muscle (CrATSM/). This strategy
resulted in 80%–90% loss of CrAT activity in skeletal muscles
without affecting the heart (Figure S2D). Residual activity was
highest in soleus and red quadriceps (Figure S2E). Muscle
quantities of acetyl-CoA, the principal substrate of CrAT,
were increased 1.8-fold in whole quadriceps from CrATSM/
as compared to control mice (Figure S1F), whereas the muscle
pool of acetylcarnitine was only 27% lower (Figure S2F), possibly
due to residual CrAT activity and/or exogenous supply of the
metabolite.
We next subjected CrATSM/ mice and littermate controls to
two different treadmill protocols (Figure 2A), both designed to
challenge the capacity of the muscle to cope with several
abrupt increments in energy demand. The first was an endur-
ance protocol with high-intensity ramping during the latter
half of the run. Time and distance to exhaustion during the
ramping period were decreased 18% and 29%, respectively,
in CrATSM/ compared to CrATfl/fl mice (Figure 2B). During a
second, higher intensity test, the frequency and magnitude of
the increments were increased, and whole-body respiration
was monitored by indirect calorimetry. Again, the CrATSM/
mice performed poorly and completed only 66% of the distance
covered by the control group (Figure 2C). CrATSM/ mice
tended to have higher O2 consumption and lower CO2 produc-
tion throughout the exercise, as well as a lower peak respiratory
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Figure 1. CrAT Fiber Type Distribution and
Regulation by Exercise
(A–E) (A) CrAT protein abundance was determined
in 3-month-old rat heart, red quadriceps (RQ), red
gastrocnemius (RG), tibialis anterior (TA), soleus
(SOL), plantaris (Plant), white gastrocnemius (WG),
white quadriceps (WQ), EDL and liver tissue ho-
mogenates, and (B) isolated mitochondria. Values
are expressed as a.u. CrAT mRNA expression
normalized to 18S was determined in (C) mouse
tibialis anterior muscle at rest and 15min, 3 hr, and
24 hr after a 90 min exercise bout; (D) tibialis
anterior muscle from MCK-Pgc1a transgenic and
non-transgenic (NT) control mice; and (E) primary
human skeletal myocytes treated with recombi-
nant adenovirus encoding b-galactosidase or rat
Pgc1a.
(F) [13C2]Acetylcarnitine content (pmol/muscle) of
the incubation buffer was measured after isolated
mouse soleus muscles were incubated in KHB
buffer supplemented with 5 mM [U-13C] glucose
and 2 mM [U-13C pyruvate] for 30 min of rest (R),
followed by electrically stimulated contraction
(CONT) and recovery. Data are means ± SEM
(n = 3-5). *p < 0.05.exchange ratio (RER) of 0.931 compared to 0.992 in the CrATfl/fl
controls (Figures 2D–2F).
Because a reduction in RER typically reflects a substrate shift
in favor of fat oxidation, we examined possible changes in
b-oxidation potential using mitochondria isolated from gastroc-
nemius muscles. Consistent with the whole-body measures,
maximal rates of palmitoylcarnitine (PC)-supported respiration
were increased 38% in mitochondria harvested from CrAT-defi-
cient versus control muscles (Figure 2G). This was accompanied
by 1.5- to 2.0-fold increases in muscle mRNA expression of
several b-oxidation enzymes (Figure 2H). We suspect that upre-
gulation of the b-oxidation machinery might be due in part to
elevated tissue levels of long-chain acyl-CoAs (Muoio et al.,
2012) andconsequent activation of lipid-responsive transcription
factors such as PPARa and PPARd (Muoio et al., 2002). Collec-
tively, these results revealed an atypical physiologic phenotype
wherein enhanced capacity for fat oxidation was accompanied
by reduced exercise tolerance. Since heavy reliance on fat oxida-
tion diminishes respiratory efficiency (lower P/O ratio), the failure
of CrATSM/ mice to fully shift to carbohydrate oxidation at
higher workloads might have contributed to early fatigue.Cell Metabolism 22,CrAT Deficiency Disrupted
Acetyl-CoA Buffering Capacity and
Exercise Bioenergetics
To gain insight into the biochemical
underpinnings of premature fatigue in
CrATSM/ mice, we evaluated muscle
metabolite levels prior to exhaustion,
using tissues collected from a second set
of mice that were subjected to only
12 min of high-intensity treadmill running.
Metabolitesweremeasured in quadriceps
muscles harvested 10 min or 1 hr after
exercise cessation and compared againstthose from rested controls. In CrATfl/fl control mice, muscle con-
centrations of both acetylcarnitine (Figure 3A) and acetyl-CoA
(Figure 3B) were remarkably stable at these time points. By
contrast, acetylcarnitine/acetyl-CoA balance fluctuated dramati-
cally in muscles from the CrATSM/mice (Figure 3C). Acetylcar-
nitine content in muscles from CrATSM/ trended lower in the
rested state (Figure 3A) but then increased to levels comparable
to the control group during the post-exercise period, whichmight
reflect contraction-stimulated uptake of acetylcarnitine as sug-
gested by results shown in Figure 1F. Conversely, acetyl-CoA
concentrations in muscles from CrATSM/ versus CrATfl/fl mice
were elevated 2-fold at rest but then fell dramatically in response
to exercise, implying a connection between acetyl group deficit
and early fatigue. In CrATSM/ mice, acetyl-CoA levels were
partly restoredduring the1hr recoveryperiod,whereasacetylcar-
nitine remained elevated. Because muscle concentrations of free
carnitine and CoA were similar between genotypes and unaf-
fected by exercise at the time points measured, the dramatic
shifts in the acetylcarnitine/acetyl-CoA ratio in the knockout
mice (Figure 3C) reflect a directionally similar shift in the disequi-
librium ratio (r), such that mass action immediately after exercise65–76, July 7, 2015 ª2015 Elsevier Inc. 67
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Figure 2. CrAT Deficiency Compromises
Exercise Performance despite Increased
Fat Oxidation
(A) 12-week-old male and female mice ran to
exhaustion in two separate experiments using two
distinct graded treadmill protocols (n = 11, 6M and
5 F mice per group).
(B) Time and distance to exhaustion measured
during the ramping period of the endurance
protocol.
(C–F) (C) Time and distance to exhaustion
measured during high-intensity exercise. Indirect
calorimetry was performed using an enclosed
metabolic treadmill, and (D) VO2, (E) VCO2, and (F)
RER were calculated.
(G) Mitochondria isolated from gastrocnemius
muscles of CrATfl/fl and CrATSM/ littermates
were used to assess state 3 respiration in the
presence of 2 mM malate; 1 mM carnitine; and 5,
10, or 20 mM PC (n = 5 M mice).
(H) mRNA expression normalized to 18S was
determined for carnitine palmitoyltransferase 1
(Cpt1), carnitine acylcarnitine translocase (Cact),
carnitine palmitoyltransferase 2 (Cpt2), very-
long-chain acyl-CoA dehydrogenase (Vlcad)
and medium-chain acyl-CoA dehydrogenase
(Mcad) in CrATfl/fl and CrATSM/ mouse
gastrocnemius muscle (n = 6 M mice). Data are
means ± SEM. * genotype effect (p < 0.05).favored the reverse CrAT reaction (i.e., acetyl-CoA production).
This observation is consistentwith thepremise that during intense
exercise CrAT catalyzes net flux in the direction of acetyl-CoA.
Abrupt fluctuations in muscle energy demand are immediately
buffered by phosphocreatine (PCr), which donates its high-en-
ergy phosphoryl group to ADP in a freely reversible phospho-
transfer reaction catalyzed by creatine kinase (CK). Muscle
contraction favors CK flux in the forward direction to generate
ATP and Cr, whereas the opposite holds true during exercise re-
covery. Because the limited myocellular storage pools of PCr
can provide for only a few seconds of maximal activity, contin-68 Cell Metabolism 22, 65–76, July 7, 2015 ª2015 Elsevier Inc.uous regeneration of PCr is critical
to muscle performance and recovery.
Within 10 min of exercise cessation, the
PCr pool in muscles from control mice
was not only fully replenished, but was
actually elevated compared to the rested
state (Figures 3D and S3; Table S1). This
post-exercise overshoot is typical of
a short-duration, high-intensity activity
and indicative of robust cardiometabolic
fitness (Korzeniewski and Zoladz, 2005;
Sahlin et al., 1997). Notably, CrAT-defi-
cient muscles appeared to lose capacity
to quickly stockpile PCr during the same
recovery period (Figures 3D and S3;
Table S1). Deficiencies in oxidative ATP
production increase reliance on glycol-
ysis and thus muscle glycogen reserves.
Interestingly, in the rested state, mus-
cle glycogen levels were elevated inCrATSM/ mice, perhaps due to the foregoing shift in substrate
selection (Figure 3E). However, despite elevated fat oxidation
during the treadmill test (Figure 3E), exercise-induced depletion
of muscle glycogen was 3.5-fold greater in the CrATSM/ mice
(Figure 3F). Blood lactate levels increased from 3.8 ± 0.39 mM at
rest to 12.0 ± 1.1 mM at 5 min post-exercise, but they were sur-
prisingly similar between genotypes. CrAT deletion did not affect
muscle fiber type composition (Figures 3G and 3H).
In aggregate, these findings support previous studies point-
ing to substrate deficit as a factor that limits mitochondrial
flux at the onset of exercise. Much of the earlier work on this
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Figure 3. CrAT Deficiency Disrupts Muscle
Acetyl-CoA Balance and Bioenergetics
during and after Exercise
(A–F) Quadriceps muscles were harvested from
male CrATfl/fl and CrATSM/ littermates at rest or
10 min and 1 hr after 12 min of high-intensity ex-
ercise. Tandem mass spectrometry was used to
measure muscle concentrations of (A) ace-
tylcarnitine, (B) acetyl-CoA, and (C) the ratio of
acetylcarnitine:acetyl-CoA. The same muscles
were used to measure (D) PCr, (E) glycogen, and
(F) exercise-induced glycogen breakdown, calcu-
lated as the difference between pre- and post-
exercise.
(G) Quantified plantaris muscle fiber type compo-
sition data (triplicate sections counted).
(H) Representative fiber type images from
plantaris; blue (type 1), red (2a), green (2b), un-
stained (2x). Data are means ± SEM, n = 4–8
per group. ^ exercise effect; * genotype effect
(p < 0.05).topic centered on exercise-induced activation of PDH, the
mitochondrial enzyme complex that converts pyruvate to
acetyl-CoA. PDH activity increases upon dephosphorylation
of the complex, which depends on the balance of upstream ki-
nase and phosphatase enzymes that receive input from a num-
ber of metabolic cues. Delayed activation of PDH at the onset
of exercise is presumed to limit acetyl-CoA availability and
TCAC flux, thereby restricting OXPHOS. Evidence favoring
this hypothesis comes from several studies showing that
administration of a pharmacological PDH activator, dichloroa-
cetate (DCA), immediately prior to moderately intense exercise
(65% VO2 max) enhances oxidative metabolism and dimin-
ishes reliance on substrate phosphorylation from the PCr/CK
and glycogenolytic/glycolytic reactions (Howlett et al., 1999;
Timmons et al., 2004). Interestingly, this maneuver also resulted
in rapid expansion of the muscle acetylcarnitine pool and
improved exercise performance (Durkot et al., 1995; Ludvik
et al., 1993; Timmons et al., 1996, 1998), implying that sub-
strate availability plays a role in optimizing aerobic ATP produc-
tion during transitions of escalating workload. Accordingly, we
performed western blot analysis of PDH phosphorylation at ser-
ines 293 and 300, which inactivates the enzyme. The results re-
vealed a trend toward increased pPDH in the knockout mice,
consistent with a possible limitation in pyruvate flux (Figure S3).
Taken together, these findings provide strong support for the
acetyl group deficit theory of muscle fatigue and offer the first
conclusive evidence that CrAT is essential for optimizingCell Metabolism 22,acetyl-CoA balance and muscle energy
economy during and after exercise.
Exogenously Supplied
Acetylcarnitine Delayed Fatigue
and Improved Energy Economy in a
CrAT-Dependent Manner
Results of the exercise tolerance studies
suggested that CrAT-derived acetylcarni-
tine supports mitochondrial respiration
when production of acetyl-CoA fromother fuel sources becomes limiting. This hypothesis was subse-
quently tested in isolated mitochondria, which maintained high
rates of acetylcarnitine-supported respiration in a CrAT-depen-
dent manner (Figure 4A). Using mitochondria from wild-type
mice, we measured respiration in the presence of saturating
levels of malate and ADP along with increasing doses of either
PC or acetylcarnitine. Acetylcarnitine permitted higher maximal
rates of respiration than PC, although the concentration required
for saturation was much greater (Figure 4B). In a subsequent
experiment, addition of submaximal concentrations of acetylcar-
nitine to mitochondria respiring on a saturating dose of PC
further increased rates of oxygen consumption (Figure 4C). By
contrast, addition of free carnitine, which promotes acetylcarni-
tine efflux, lowered respiration.
Results presented in Figures 1F and 3A suggested that exer-
cise might stimulate muscle acetylcarnitine uptake. To test
this possibility, we used the muscle bath incubation system to
examine contraction-induced changes in the oxidation rates of
exogenously supplied [14C]acetylcarnitine. Extensor digitorum
longus (EDL) muscles were selected for this analysis based on
their fiber type properties, high level of mitochondrial CrAT con-
tent (Figure 1B) and low residual activity in the knockout mice. As
predicted, electrical stimulation applied during a 10 min incuba-
tion caused a marked 5-fold increase in acetylcarnitine catabo-
lism to [14C]CO2 as compared to rested/unstimulated muscles
(Figure 4D). This outcome was fully dependent on CrAT activity.
Moreover, in control muscles, provision of 5 mM acetylcarnitine65–76, July 7, 2015 ª2015 Elsevier Inc. 69
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Figure 4. Exogenously Supplied Acetylcar-
nitine Delayed Fatigue and Improved Energy
Economy in a CrAT-Dependent Manner
(A–C) Mitochondria isolated from gastrocnemius
muscles of CrATfl/fl and CrATSM/ male mice
were used for Seahorse-based assessment of
state 3 oxygen consumption rates (OCRs) in the
presence of (A) 1.0–10 mM acetylcarnitine, (B)
saturating doses of PC compared to acetylcarni-
tine (AC) (20 mM and 10 mM, respectively), or (C)
a saturating dose of PC followed by addition of
vehicle, 5 mM AC, or L-carnitine (n = 5) and then
rotenone and antimycin A (AntA).
(D–F) (D) Contraction-induced oxidation [14C]
Acetylcarnitine to [14C]CO2 was assessed in intact
EDL muscles from CrATfl/fl and CrATSM/mice at
rest and after 4 and 10 min electrical stimulation at
12.5 V per chamber (n = 4). Time to half maximal
force generation (t1/2) was determined using EDL
muscles from (E) CrATfl/fl and (F) CrATSM/ mice
in the absence or presence of 5 mM AC stimulated
at 20 V per chamber (n = 6).
(G and H) In separate experiments, EDL muscles
were flash frozen after a 4 min stimulation ± 5 mM
AC and used for measuring the ratios of (G) PCr/
Creatine (H) AMP/ATP. Data are means ± SEM,
n = 5–10 per group.* effect of AC (p < 0.05).diminished the rate of fatigue, such that time to half maximal
force generation during a high-intensity regimen increased by
50% (Figure 4E). By contrast, acetylcarnitine had no effect
on the force-fatigue properties of EDL from CrATSM/ mice
(Figure 4F).
We repeated these experiments and assessed muscle energy
charge after 4min of contraction. As expected, pilot experiments
performed with control mice confirmed robust contraction-
induced shifts in muscle content of high-energy phosphagens
(Table S2). In control but not CrAT-deficient muscles, exoge-
nously supplied acetylcarnitine defended the muscle PCr pool,
resulting in a near 2-fold increase in the post-contraction PCr/
Cr ratio (Figures 4G and S4; Table S3). This observation is func-
tionally relevant because a decline in the PCr/Cr ratio limits for-
ward flux through the CK reaction and thereby diminishes
maximal power output during exercise. In addition to the CK re-70 Cell Metabolism 22, 65–76, July 7, 2015 ª2015 Elsevier Inc.action, adenylate kinase also plays a key
role in exercise bioenergetics by cata-
lyzing phosphoryl group transfer from
one ADP to another, thereby regenerating
one ATP along with AMP. The latter mole-
cule can then be deaminated to produce
IMP as a critical step in the adenine
nucleotide cycle. When acetylcarnitine
was provided to control muscles, post-
contraction levels of the adenine nucleo-
tides reflected a favorable shift in energy
charge. Thus, acetylcarnitine lowered
both the AMP/ATP and IMP/ATP ratios
(Figures 4H and S4; Table S3), consistent
with improved metabolic stability. By
contrast, these same indices of energystress were completely unresponsive to the acetylcarnitine treat-
ment in muscles from CrATSM/ mice.
Carnitine Supplementation Enhanced Exercise
Performance in Control but Not CrATSM–/– Mice
To determine whether the benefits of enhanced acetyl group
buffering capacity would take effect at a whole-body level, we
performed the same two graded treadmill tests described in Fig-
ure 2, but after 2 and 4 weeks of dietary L-carnitine supplemen-
tation. Consistent with previous reports (Makowski et al., 2009;
Noland et al., 2009), administration of L-carnitine in the drinking
water for 2 weeks increased resting blood levels of free carnitine
and acetylcarnitine by 30% and 20%, respectively, regardless of
genotype (Figures 5A and 5B). In control mice, two and 4 weeks
of L-carnitine supplementation improved distance to exhaustion
by 30% and 27% during the endurance with ramping and the
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Figure 5. Dietary L-Carnitine Supplementa-
tion Enhanced Exercise Performance in
Control but Not CrATSM–/– Mice
(A–D) Male mice were randomly selected to
receive supplementation with pH-neutralized
drinking water ± 1.0 mg/ml L-carnitine for 4 weeks.
Tandem mass spectrometry was used to assess
(A) free carnitine and (B) acetylcarnitine in blood
spots taken from the tail vein after 2 weeks of
treatment. Running time and distance to exhaus-
tion were determined in two separate experiments
using treadmill protocols consisting of (C) endur-
ance exercise with high-intensity ramping (data
shown for the ramping period only) or (D) high-in-
tensity exercise after 2 and 4 weeks of supple-
mentation, respectively.
(E and F) In a separate endpoint experiment,
plasma and quadriceps muscles were collected
after 90 min of endurance running with ramping
(100 PostEx) and used for measurement of (E)
plasma acetylcarnitine and (F) total carnitine
(free carnitine + acetylcarnitine) in muscle. Data
are means ± SEM, n = 6 per group. * carnitine
effect; ^ genotype effect (p < 0.05).high-intensity regimens, respectively. This carnitine-mediated
improvement of exercise performance was absent in the
CrATSM/ mice (Figures 5C and 5D). Serum acetylcarnitine
levels measured 10 min after the second treadmill test were
increased 34%–38% in both carnitine supplemented groups
(Figure 5E). Thus, in line with results of the muscle incubation
experiments (Figures 4E and 4F), increased supply of acetylcar-
nitine to working muscles was accompanied by enhanced exer-Cell Metabolism 22,cise tolerance in CrATfl/fl mice but not
their CrATSM/ counterparts. Despite
the robust impact on performance, carni-
tine supplementation did not alter intra-
muscular levels of free, esterified, or total
carnitine measured 10 min after exercise
(Figure 5F), suggesting rapid equilibration
of the muscle carnitine pool upon exer-
cise cessation due to consumption
and/or efflux of acetylcarnitine during
recovery (Figure 1F).
Exercise Alters Acetylcarnitine
Dynamics in Humans
Lastly, we sought to evaluate the transla-
tional relevance of these findings in
humans. To this end, CrAT protein abun-
dancewas found tobe elevated in skeletal
muscle biopsy specimens from trained
athletes as compared to age-matched
untrained subjects, and trended lower
in muscle from older, type 2 diabetic
subjects (Figure 6A). Protein abundance
correlated strongly with muscle CrAT ac-
tivity (Figure 6B), and enzyme activity
was positively associated with mitochon-
drial function, assessed in vivo by deter-mining PCr recovery kinetics after exercise using magnetic reso-
nance spectroscopy (MRS) (Figure 6C), as recently described
(Lindeboom et al., 2014). We then conducted a small pilot study
in a separate cohort of trained and untrained subjects in which
a newly developed MRS technique was used to examine in vivo
muscle acetylcarnitine content before and muscle content and
kinetics after 30min on a cycle ergometer at 50%maximal work-
load. A dramatic between-group difference was observed in65–76, July 7, 2015 ª2015 Elsevier Inc. 71
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Figure 6. CrAT Expression and Acetylcarnitine Levels in Human
Medial Vastus Lateralis Muscle
(A) CrAT protein abundance measured in muscle biopsy specimens collected
from exercise-trained (T), untrained (UT), and type 2 diabetic (T2D) subjects
(n = 6-11).
(B) Relationship between CrAT protein abundance and CrAT activity.
(C) Relationship between CrAT activity and PCr recovery rates measured by
31P-MRS after 5 min of exercise.
(D) Muscle levels of acetylcarnitinemeasured in trained and untrained subjects
by 1H-MRS before, 15 min after, and during recovery from 30 min of cycle
ergometer exercise performed at 50% of maximal workload (n = 4 to 5). Data
are means ± SEM.exercise-induced acetylcarnitinemetabolism.Whereas the cycle
exercise increased tissue acetylcarnitine content in both groups,
peak accumulation immediately after exercise was markedly
lower in the trained group, suggesting increased consumption
(Figure 6D). Moreover, during the 40 min recovery period, the
acetylcarnitine signal decayed rapidly in the trained group but
continued to rise in the untrained subjects.
Although further studies are necessary to better understand
whole-body acetylcarnitine flux in humans, these findings align
with the notion that training-induced upregulation of CrAT in hu-
mans influences muscle bioenergetics and acetyl group balance
during and after exercise. Conversely, low CrAT activity, which
has been observed in the contexts of aging, obesity, and dia-
betes, might exacerbate muscle fatigue (Muoio et al., 2012; No-
land et al., 2009; Seiler et al., 2014). Also noteworthy is that pre-
vious studies in humans using either proton MRS (Ren et al.,
2013) or biochemical methods (Stephens et al., 2007) showed
that mid- to high-intensity muscle contraction shifts the tissue
carnitine pool from a principally non-esterified to a mostly ester-
ified state, suggesting that availability of free carnitine could limit
CrAT activity under these circumstances. Moreover, systemic
carnitine homeostasis can be compromised by aging, obesity,
cardiometabolic disease, hepatic steatosis, and use of drugs
that form carnitine conjugates (Costell et al., 1989; Evangeliou
and Vlassopoulos, 2003). Together with current study, these
findings imply that nutritional or pharmacological strategies
aimed at increasing acetyl-CoA buffering capacity have the po-
tential to augment energy efficiency and delay muscle fatigue72 Cell Metabolism 22, 65–76, July 7, 2015 ª2015 Elsevier Inc.and might prove beneficial for treating some patients with exer-
cise intolerance (Brevetti et al., 1991; Wall et al., 2011).
Working Model of CrAT Flux during Exercise
Whereas our results provide strong evidence that CrAT activity
influences muscle energetics and contractile performance,
delineating the biophysical basis of this finding is not as straight-
forward.Weconsider three explanations as illustrated in Figure 7.
First, acetylcarnitine derived from both local and circulating
pools might serve as an important acetyl group donor during
brief periods when rates of OXPHOS exceed acetyl-CoA pro-
duction from PDH and b-oxidation. This possibility is supported
by our evidence that muscle clears and oxidizes exogenously
supplied acetylcarnitine during contractile activity and that
provision of acetylcarnitine delayed fatigue in isolated working
skeletal muscles. However, because blood concentrations of
acetylcarnitine are in the low mM range, we presume that acetyl-
carnitine supply from the periphery to workingmuscles accounts
for only a small fraction of total ATP demand. Additionally, ace-
tylcarnitine metabolites might be transferred between neigh-
boring myofibers. For example, perhaps highly oxidative type I
myofibers with elevated mitochondrial content but lower force-
generating potential shuttle surplus acetylcarnitine to more
powerful, ATP-consuming type II fibers. To this point, we found
that CrAT protein levels were most abundant in isolated mito-
chondria from muscles enriched in type IIa fibers (Bloemberg
and Quadrilatero, 2012). Thus, mitochondria resident in type IIa
myofibers might have a greater need for acetylcarnitine sub-
strate to meet the energetic demands of mid- to high-intensity
workloads.
Second, by residing in close proximity to various enzymatic
sources of acetyl-CoA, CrAT could function to alleviate kinetic
hindrances due to product inhibition while also regenerating
essential cofactors (CoA) necessary for continued catabolic
flux. For example, acetyl-CoA inhibits PDH by activating one or
more of its four known PDH kinases (PDK1–4), which phosphor-
ylate and inactivate the E1a subunit of the complex (Sugden and
Holness, 2003). Acetyl-CoA and free CoA compete for binding to
the complex, and thus, small shifts in the local acetyl-CoA/CoA
ratio can contribute to substantive changes in enzyme activity.
Accordingly, provision of L-carnitine was previously shown to in-
crease both PDH activity and pyruvate-supported respiration
in isolated mitochondria from control but not CrAT-deficient
muscles (Fisher-Wellman et al., 2015; Muoio et al., 2012).
Lastly, a third model positions CrAT as a conduit for acetyl
group transfer. This possibility emerges from studies that used
hyperpolarized 13C MRS to examine acetylcarnitine dynamics
in perfused working heart. Investigators estimated that under
the conditions of these experiments, 50% of pyruvate-derived
citrate cycles through the acetylcarnitine pool before entering
the TCAC (Schroeder et al., 2012). Similarly, another study that
used a mass-spectrometry-based tracer approach concluded
that pyruvate-derived acetyl-CoA is preferentially channeled to
CrAT (Li et al., 2015). Based on these and the current results,
we envision a key role for CrAT in metabolic channeling. Thus,
flux through the CrAT reaction during exercisemight permit rapid
and efficient delivery of acetyl groups from their site of produc-
tion to citrate synthase (Figure 7). By acting as a shuttle system
for acetyl group transfer, CrAT would be predicted to overcome
Figure 7. Proposed Role of CrAT in Mitochondrial Acetyl-CoA Buffering and Acetyl Group Transfer during Exercise
Acetyl-CoA is the universal catabolic intermediate that fuels the TCAC, which in turn serves as the main source of reducing equivalents (NADH) that support
oxidative regeneration of ATP and PCr by the ETC andmitochondrial CK. During transitions from low to high exercise workloads, TCAC fluxmust increase to keep
pace with the high ATP demands of muscle contraction. A shortfall in acetyl-CoA provision will force heavy reliance on substrate-level phosphorylation, resulting
in depletion of PCr andmuscle glycogen reserves, alongwith production of lactic acid and other deleteriousmetabolic byproducts. CrAT functions to sustain high
rates of oxidative ATP regeneration via three proposed mechanisms. First, contraction-induced recycling and/or import of acetylcarnitine (AcCarn) supplies a
readily available source of acetyl group donors to buffer transient deficits in glucose, amino acid, and fatty acid catabolism. Second, by residing in close proximity
to the various enzymatic sources of acetyl-CoA (e.g., PDH and ketothiolase [KT]), CrAT alleviates product inhibition of metabolic enzymes while also regenerating
essential cofactor (CoA) necessary for continued catabolic flux. Third, CrAT permits rapid and efficient delivery of acetyl groups from their site of production to the
TCAC (blue arrows). Thus, by acting as a conduit for acetyl group transfer, CrAT overcomes the thermodynamic inefficiency of diffusional flux, which requires an
energetically unfavorable gradient profile (black triangle).the thermodynamic inefficiencies of diffusional flux, which re-
quires an energetically unfavorable gradient profile (Aliev et al.,
2011). This paradigm of substrate transfer through a series of
near-equilibrium reactions is conceptually analogous to the
phospho-energy transfer networks driven by the adenylate ki-
nase and CK systems (Dzeja and Terzic, 2003; Sweeney, 1994).
The foregoing mechanisms could act simultaneously if acetyl-
carnitine produced by the PDH complex under high-flux condi-
tions is efficiently recycled, while exogenously supplied and/or
the local storage pool of acetylcarnitine also contribute to citrate
synthase flux. Notably, the affinities of CrAT, PDH, and citrate
synthase for acetyl-CoA align with this possibility. For example,
the Km of citrate synthase for acetyl-CoA is approximately 10-
fold lower than CrAT, whereas the Ki of acetyl-CoA for PDH
and the PDKs is roughly equivalent to its Km for CrAT. This sug-
gests that CrAT has the potential to modulate PDH flux without
competing with citrate synthase. We therefore propose that
CrAT runs in the forward direction in the vicinity of PDH, while
running in the reverse direction near citrate synthase, such that
net flux through CrAT during exercise favors acetyl-CoA produc-tion, at least in some fibers. This model is supported by results of
Schroeder et al. (2012), showing that the CrAT reaction con-
tinues to run in the reverse direction even during supraphysiolog-
ical supply of acetyl-CoA via PDH and that the total acetylcarni-
tine pool in heart decreases upon increasing cardiac workload.
In sum, we have shown that CrAT-mediated acetyl group buff-
ering is critical for muscle contractile performance and fatigue
resistance and that acetylcarnitine has a metabolic purpose dur-
ing exercise. The findings also imply that CrAT maintains the
acetyl-CoA microenvironment of specific mitochondrial enzyme
complexes inamanner thepermits optimal TCACfluxandaerobic
power.Thisworkspeaks to long-standingquestionson the impor-
tance ofmetabolic inertia and acetyl deficit as limiting factors dur-
ing exercise and advances the concept of metabolic channeling.EXPERIMENTAL PROCEDURES
Animals
Animal studies were approved by the Duke University Institutional Animal
Care and Use Committee. Generation of the Crat homozygous floxed controlCell Metabolism 22, 65–76, July 7, 2015 ª2015 Elsevier Inc. 73
(Cratfl/fl) mice has been described (Muoio et al., 2012). Skeletal-muscle-spe-
cific knockout mice (CratSKM/) were generated by breeding Cratfl/fl mice
with transgenic mice expressing Cre recombinase under control of the mouse
myogenin promoter and MEF2C (myo-CreTg/0), which express Cre recombi-
nase exclusively in skeletal muscle but not heart. All lines were backcrossed
>6 generations to the C57BL/6 background. Animals were housed in a temper-
ature-controlled environment with a 12 hr light:12 hr dark cycle and allowed ad
libitum access to standard chow (Purina Rodent Chow no. 5001, Purina Mills)
and water. Studies were performed in male animals unless otherwise noted in
the figure legends. We found no interactions between sex and genotype.
Mitochondrial Isolation
Skeletal muscle mitochondria were prepared according to DeBalsi et al.
(2014).
Carnitine Acetyltransferase Activity
Tissues were ground into powder and processed in CelLytic MT buffer (Sigma
Chemicals) by freeze fracturing three timesandsonicationatfive times1spulses
on setting five. CrAT activity was assessed according to Seiler et al. (2014).
Western Blots
Protein was isolated using CelLytic MT lysis buffer (Sigma Chemicals) and
quantified by using a bicinchoninic acid (BCA) kit (Sigma Chemicals). Protein
(50 mg from cell/tissue lysates) was separated by SDS-PAGE, transferred
to nitrocellulose, and incubated with antibodies prepared with fish gelatin
blocking buffer (0.5% fish gelatin, 13 PBS, 1 mg/ml casein, and 15 mM
NaN3). IgG-congugated AlexFluor fluorescent secondary antibodies (Invitro-
gen) were used with the Li-COR (Li-COR Biosciences) to visualize bands. Pro-
tein expression was normalized to total protein as determined by MemCode
staining (Thermo Scientific). The primary CrAT antibody was a generous gift
from the laboratory of Dr. Fausto Hegardt.
Metabolite Analysis
Tissue and plasma samples were processed and analyzed as described in
Muoioetal. (2012)andNolandetal. (2009).Detailedmethods for themass-spec-
trometry- and MRS-based measurements of metabolites in mouse and human
muscles are provided in the Supplemental Information. PCr and creatine anal-
ysis was performed according to Harris et al. (1974) and Bergmeyer (1974).
Glycogen Content
500 ml of 1 N HCl was added to 20 mg of powdered skeletal muscle in a 2.0-ml
screw top tube and homogenized at 25,000 rpm for 30 s. Samples were boiled
for 90 min, tubes were cooled to room temperature, and 0.5 ml of 1 N NaOH
was added. Glycogen content was assessed at 340 nm after addition of
glucose assay reagent (Sigma).
Fibertype Analysis
Plantaris muscles were embedded in OCT and tragacanth before being frozen
in liquid-nitrogen-cooled 2-methylbutane and stored at 80C. 8 mm sections
were prepared and fixed in cold acetone for 2 min, washed in 13 PBS, and
blocked for 1 hr at room temperature in 10% normal goat serum before incu-
bation in the following antibodies: BA-F8 MHC type 1 (1:100); BF-F3 MHC 2b
(1:200) and SC-71 MHC-2a (Developmental Studies Hybridoma Bank, Univer-
sity of Iowa); and Alexa Fluor conjugated secondary antibody cocktail (1:100)
555, 647, and 488 (Invitrogen) at room temperature for 30 min in the dark.
Slides were mounted in FluorSave Reagent (Calbiochem) and imaged on a
Zeiss Axioplan 2, and fiber type composition was quantified using ImageJ.
Exercise Studies
Exercise studies were carried out in a blinded fashion. 3 days prior to the
experiment, mice were acclimated via exposure to a 3 min run with 1 min at
each of the first three speeds in the respective protocol being tested. Exhaus-
tion was defined as remaining on the shock grid for more than 10 s with
nudging.
High Intensity
Exercise capacity during high-intensity running was determined using an en-
closed treadmill (Columbus instruments) attached to a Comprehensive Labo-
ratory Animal Monitoring System (CLAMS) with a fixed incline of 10. Mice74 Cell Metabolism 22, 65–76, July 7, 2015 ª2015 Elsevier Inc.began running at 14 m/min, and speed increased 3 m/min every 3 min until
exhaustion. Measurements were collected every 30 s. Airflow was set to 0.6
l/min. Blood blood lactate was measured with a Lactate Plus lactometer
(Nova Biomedical).
Endurance with High-Intensity Ramping
The transition from endurance to high-intensity running was completed with a
fixed slope of 10. Mice began running at 8 m/min, and speed increased
2 m/min every 15 min for 1 hr before transitioning to 20 m/min for 1 min, then
23m/min for 10min, with an increaseof 3.5m/min every 10minuntil exhaustion.
Distance and time to exhaustion presented reflect the ramp up period only.
For the carnitine supplementation experiment, mice were randomly selected
to receive 2 weeks of supplementation with pH-neutralized drinking water ±
1.0 mg/ml L-carnitine. After exercise, mice were anesthetized using an intra-
peritoneal injection of 100 mg/kg body weight Nembutal. Tissue samples
were harvested approximately 10 min after cessation of exercise, frozen
immediately in liquid nitrogen, and stored at 80C.
Ex Vivo Muscle Stimulation and Acetylcarnitine Oxidation
Braided silk suture loops were attached to muscle tendons and excised from
the mouse. Muscles were placed in pre-warmed KHB buffer (pH 7.4) contain-
ing (in mmol/l) 118 NaCl, 4.7 KCl, 2.52 CaCl2, 1.64 MgSO4, 24.88 NaCO3, 1.18
KH2PO4, 5.5 glucose, and 2.0 Na-pyruvate. After placement in a Radnoti 2 ml
tissue bath system,muscles were tensed to 1 g and allowed to relax for 15min.
Muscles were then re-tensed to 1 g and allowed to rest 5 min, which was
repeated three times. KHB buffer was used in muscle transport and tensing,
whereas low-glucose KHB (2 mM glucose, no pyruvate) was used during stim-
ulation to mimic an energy-stressed state. The following stimulation protocol
was used unless otherwise stated: stimulation rate, 60 pps; delay, 2,000 ms;
duration, 300 ms; and volts, 20 per chamber. O2 flow and temperature
(25C) were kept constant throughout stretching and stimulation. Acetylcarni-
tine (Sigma) was made up at 1 M in H2O and added at a final concentration of
5 mM to stimulatedmuscles 30 s after initiation of contraction. This allowed for
normalization of contracting muscles prior to adding acetylcarnitine. Acetyl-
carnitine oxidation was assessed by capturing media [14C]CO2 from 200 mM
[1-14C]acetylcarnitine (ARC 1615) during rest or stimulation. Oxidation studies
were done in low-glucose KHB buffer with 3 mg/ml HEPES added. Acetylcar-
nitine efflux experiments were conducted with isolated soleus muscles from
wild-type mice incubated in KHB buffer supplemented with 3 mg/ml HEPES,
5mM [U-13C] glucose, and 2mM [U-13C] pyruvate. Buffer was sampled before,
during, and after contraction using the following stimulation protocol: stimula-
tion rate, 60 pps; delay, 2,000 ms; duration, 300 ms; volts, 12.5 per chamber;
and time, 10 min. [13C2]acetylcarnitine was quantified by standard isotope
dilution methodology using D3 acetylcarnitine as the internal standard after
correcting for the natural abundance of the M+1 peak of the [2-13C]acetylcar-
nitine peak. This correction was determined empirically from a spectrum of
[2-13C]acetylcarnitine with no added internal standard.
Statistics
Statistical analyses were performed using SigmaStat (SysStat Software, Inc.)
or the Microsoft Excel statistical package. Within-group responses to experi-
mental manipulations were evaluated using a paired t test, where appropriate.
All data are presented asmean ± SEM, and the level of significancewas estab-
lished a priori at p less than or equal to 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, three tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.cmet.2015.06.003.
AUTHOR CONTRIBUTIONS
Conceptualization: D.M.M. and T.R.K.; methodology: T.R.K., D.M.M., P.S.,
and V.B.S.-H.; investigation: S.E.S., T.R.K., J.R.G., R.D.S., O.R.I., K.E.W.,
A.H.W., K.L.D., M.N.D., L.L., and V.B.S.-H.; writing the original draft: S.E.S.,
V.B.S.-H. T.R.K., and D.M.M.; reviewing and editing: T.R.K., D.M.M., P.S.,
and V.B.S.-H.; visualization: T.R.K. and D.M.M.; resources: D.M.M., P.S.,
and V.B.S.-H.; funding acquisition: D.M.M., P.S., and V.B.S.-H.
CONFLICT OF INTEREST
The authors have no conflict of interest to declare.
ACKNOWLEDGMENTS
The authors are supported by grants from the United States Public Health Ser-
vice R01-DK089312 (D.M.M.), 2P01-DK058398 (D.M.M.), R01-HL101189R01
(D.M.M.), F32-DK-094573 (K.E.W.), F32-DK093256 (M.N.D.), and K01-
GM1093200-01 (J.R.G.) and the American Heart Association (K.L.D.). P.S. is
supported by a VICI (grant 918.96.618) for innovative research from the
Netherlands Organization for Scientific Research (NWO). V.B.S.-H. is sup-
ported by a VENI (grant 91611136) for innovative research from the
Netherlands Organization for Scientific Research (NWO). We thank Dr. Randy
Mynatt at the Pennington Biomedical Research Center for providing theCratfl/fl
mice.
Received: November 29, 2014
Revised: March 26, 2015
Accepted: June 2, 2015
Published: July 7, 2015
REFERENCES
Aliev, M., Guzun, R., Karu-Varikmaa, M., Kaambre, T., Wallimann, T., and
Saks, V. (2011). Molecular system bioenergics of the heart: experimental
studies of metabolic compartmentation and energy fluxes versus computer
modeling. Int. J. Mol. Sci. 12, 9296–9331.
Bloemberg, D., and Quadrilatero, J. (2012). Rapid determination of myosin
heavy chain expression in rat, mouse, and human skeletal muscle using multi-
color immunofluorescence analysis. PLoS ONE 7, e35273.
Brevetti, G., Angelini, C., Rosa, M., Carrozzo, R., Perna, S., Corsi, M.,
Matarazzo, A., and Marcialis, A. (1991). Muscle carnitine deficiency in patients
with severe peripheral vascular disease. Circulation 84, 1490–1495.
Costell, M., O’Connor, J.E., and Grisolı´a, S. (1989). Age-dependent decrease
of carnitine content in muscle of mice and humans. Biochem. Biophys. Res.
Commun. 161, 1135–1143.
DeBalsi, K.L., Wong, K.E., Koves, T.R., Slentz, D.H., Seiler, S.E., Wittmann,
A.H., Ilkayeva, O.R., Stevens, R.D., Perry, C.G., Lark, D.S., et al. (2014).
Targeted metabolomics connects thioredoxin-interacting protein (TXNIP) to
mitochondrial fuel selection and regulation of specific oxidoreductase en-
zymes in skeletal muscle. J. Biol. Chem. 289, 8106–8120.
Durkot, M.J., De Garavilla, L., Caretti, D., and Francesconi, R. (1995). The ef-
fects of dichloroacetate on lactate accumulation and endurance in an exer-
cising rat model. Int. J. Sports Med. 16, 167–171.
Dzeja, P.P., and Terzic, A. (2003). Phosphotransfer networks and cellular ener-
getics. J. Exp. Biol. 206, 2039–2047.
Evangeliou, A., and Vlassopoulos, D. (2003). Carnitine metabolism and
deficit—when supplementation is necessary? Curr. Pharm. Biotechnol. 4,
211–219.
Fisher-Wellman, K.H., Lin, C.T., Ryan, T.E., Reese, L.R., Gilliam, L.A., Cathey,
B.L., Lark, D.S., Smith, C.D., Muoio, D.M., and Neufer, P.D. (2015). Pyruvate
dehydrogenase complex and nicotinamide nucleotide transhydrogenase
constitute an energy-consuming redox circuit. Biochem. J. 467, 271–280.
Greenhaff, P.L., Campbell-O’Sullivan, S.P., Constantin-Teodosiu, D.,
Poucher, S.M., Roberts, P.A., and Timmons, J.A. (2002). An acetyl group
deficit limits mitochondrial ATP production at the onset of exercise.
Biochem. Soc. Trans. 30, 275–280.
Harris, R.C., Hultman, E., andNordesjo¨, L.O. (1974). Glycogen, glycolytic inter-
mediates and high-energy phosphates determined in biopsy samples of mus-
culus quadriceps femoris of man at rest. Methods and variance of values.
Scand. J. Clin. Lab. Invest. 33, 109–120.
Hiatt, W.R., Regensteiner, J.G., Wolfel, E.E., Ruff, L., and Brass, E.P. (1989).
Carnitine and acylcarnitine metabolism during exercise in humans.
Dependence on skeletal muscle metabolic state. J. Clin. Invest. 84, 1167–
1173.Howlett, R.A., Heigenhauser, G.J., Hultman, E., Hollidge-Horvat, M.G., and
Spriet, L.L. (1999). Effects of dichloroacetate infusion on human skeletal
muscle metabolism at the onset of exercise. Am. J. Physiol. 277, E18–E25.
Bergmeyer, Hans-Ulrich (1974). Methods of Enzymatic Analysis (Academic
Press).
Korzeniewski, B., and Zoladz, J.A. (2005). Some factors determining the PCr
recovery overshoot in skeletal muscle. Biophys. Chem. 116, 129–136.
Koves, T.R., Sparks, L.M., Kovalik, J.P., Mosedale, M., Arumugam, R.,
DeBalsi, K.L., Everingham, K., Thorne, L., Phielix, E., Meex, R.C., et al.
(2013). PPARg coactivator-1a contributes to exercise-induced regulation of
intramuscular lipid droplet programming in mice and humans. J. Lipid Res.
54, 522–534.
Li, Q., Deng, S., Ibarra, R.A., Anderson, V.E., Brunengraber, H., and Zhang,
G.F. (2015). Multiple mass isotopomer tracing of acetyl-CoA metabolism in
Langendorff-perfused rat hearts: channeling of acetyl-CoA from pyruvate de-
hydrogenase to carnitine acetyltransferase. J. Biol. Chem. 290, 8121–8132.
Lindeboom, L., Nabuurs, C.I., Hoeks, J., Brouwers, B., Phielix, E., Kooi, M.E.,
Hesselink, M.K., Wildberger, J.E., Stevens, R.D., Koves, T., et al. (2014). Long-
echo time MR spectroscopy for skeletal muscle acetylcarnitine detection.
J. Clin. Invest. 124, 4915–4925.
Ludvik, B., Mayer, G., Stifter, S., Putz, D., Barnas, U., and Graf, H. (1993).
Effects of dichloroacetate on exercise performance in healthy volunteers.
Pflugers Arch. 423, 251–254.
Makowski, L., Noland, R.C., Koves, T.R., Xing, W., Ilkayeva, O.R., Muehlbauer,
M.J., Stevens, R.D., and Muoio, D.M. (2009). Metabolic profiling of
PPARalpha-/- mice reveals defects in carnitine and amino acid homeostasis
that are partially reversed by oral carnitine supplementation. FASEB J. 23,
586–604.
Muoio, D.M., MacLean, P.S., Lang, D.B., Li, S., Houmard, J.A., Way, J.M.,
Winegar, D.A., Corton, J.C., Dohm, G.L., and Kraus,W.E. (2002). Fatty acid ho-
meostasis and induction of lipid regulatory genes in skeletal muscles of perox-
isome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence
for compensatory regulation by PPAR delta. J. Biol. Chem. 277, 26089–26097.
Muoio, D.M., Noland, R.C., Kovalik, J.P., Seiler, S.E., Davies, M.N., DeBalsi,
K.L., Ilkayeva, O.R., Stevens, R.D., Kheterpal, I., Zhang, J., et al. (2012).
Muscle-specific deletion of carnitine acetyltransferase compromises glucose
tolerance and metabolic flexibility. Cell Metab. 15, 764–777.
Murias, J.M., Spencer, M.D., and Paterson, D.H. (2014). The critical role of O2
provision in the dynamic adjustment of oxidative phosphorylation. Exerc.
Sport Sci. Rev. 42, 4–11.
Noland, R.C., Koves, T.R., Seiler, S.E., Lum, H., Lust, R.M., Ilkayeva, O.,
Stevens, R.D., Hegardt, F.G., and Muoio, D.M. (2009). Carnitine insufficiency
caused by aging and overnutrition compromises mitochondrial performance
and metabolic control. J. Biol. Chem. 284, 22840–22852.
Pattyn, N., Cornelissen, V.A., Eshghi, S.R., and Vanhees, L. (2013). The effect
of exercise on the cardiovascular risk factors constituting the metabolic syn-
drome: a meta-analysis of controlled trials. Sports Med. 43, 121–133.
Pieklik, J.R., and Guynn, R.W. (1975). Equilibrium constants of the reactions of
choline acetyltransferase, carnitine acetyltransferase, and acetylcholines-
terase under physiological conditions. J. Biol. Chem. 250, 4445–4450.
Poole, D.C., and Jones, A.M. (2012). Oxygen uptake kinetics. Compr Physiol 2,
933–996.
Putman, C.T., Spriet, L.L., Hultman, E., Lindinger, M.I., Lands, L.C., McKelvie,
R.S., Cederblad, G., Jones, N.L., and Heigenhauser, G.J. (1993). Pyruvate de-
hydrogenase activity and acetyl group accumulation during exercise after
different diets. Am. J. Physiol. 265, E752–E760.
Raper, J.A., Love, L.K., Paterson, D.H., Peters, S.J., Heigenhauser, G.J., and
Kowalchuk, J.M. (2014). Effect of high-fat and high-carbohydrate diets on pul-
monary O2 uptake kinetics during the transition to moderate-intensity exer-
cise. J. Appl. Physiol. (1985) 117, 1371–1379.
Ren, J., Lakoski, S., Haller, R.G., Sherry, A.D., and Malloy, C.R. (2013).
Dynamic monitoring of carnitine and acetylcarnitine in the trimethylamine
signal after exercise in human skeletal muscle by 7T 1H-MRS. Magn. Reson.
Med. 69, 7–17.Cell Metabolism 22, 65–76, July 7, 2015 ª2015 Elsevier Inc. 75
Sahlin, K. (1990). Muscle carnitine metabolism during incremental dynamic
exercise in humans. Acta Physiol. Scand. 138, 259–262.
Sahlin, K., So¨derlund, K., Tonkonogi, M., and Hirakoba, K. (1997).
Phosphocreatine content in single fibers of humanmuscle after sustained sub-
maximal exercise. Am. J. Physiol. 273, C172–C178.
Schroeder, M.A., Atherton, H.J., Dodd, M.S., Lee, P., Cochlin, L.E., Radda,
G.K., Clarke, K., and Tyler, D.J. (2012). The cycling of acetyl-coenzyme A
through acetylcarnitine buffers cardiac substrate supply: a hyperpolarized
13C magnetic resonance study. Circ Cardiovasc Imaging 5, 201–209.
Seiler, S.E., Martin, O.J., Noland, R.C., Slentz, D.H., DeBalsi, K.L., Ilkayeva,
O.R., An, J., Newgard, C.B., Koves, T.R., and Muoio, D.M. (2014). Obesity
and lipid stress inhibit carnitine acetyltransferase activity. J. Lipid Res. 55,
635–644.
Stephens, F.B., Constantin-Teodosiu, D., and Greenhaff, P.L. (2007). New in-
sights concerning the role of carnitine in the regulation of fuel metabolism in
skeletal muscle. J. Physiol. 581, 431–444.
Sugden, M.C., and Holness, M.J. (2003). Recent advances in mechanisms
regulating glucose oxidation at the level of the pyruvate dehydrogenase com-
plex by PDKs. Am. J. Physiol. Endocrinol. Metab. 284, E855–E862.76 Cell Metabolism 22, 65–76, July 7, 2015 ª2015 Elsevier Inc.Sweeney, H.L. (1994). The importance of the creatine kinase reaction: the
concept of metabolic capacitance. Med. Sci. Sports Exerc. 26, 30–36.
Timmons, J.A., Poucher, S.M., Constantin-Teodosiu, D., Worrall, V.,
Macdonald, I.A., andGreenhaff, P.L. (1996). Increased acetyl group availability
enhances contractile function of canine skeletal muscle during ischemia.
J. Clin. Invest. 97, 879–883.
Timmons, J.A., Gustafsson, T., Sundberg, C.J., Jansson, E., Hultman, E.,
Kaijser, L., Chwalbinska-Moneta, J., Constantin-Teodosiu, D., Macdonald,
I.A., and Greenhaff, P.L. (1998). Substrate availability limits human skeletal
muscle oxidative ATP regeneration at the onset of ischemic exercise. J. Clin.
Invest. 101, 79–85.
Timmons, J.A., Constantin-Teodosiu, D., Poucher, S.M., and Greenhaff, P.L.
(2004). Acetyl group availability influences phosphocreatine degradation
even during intense muscle contraction. J. Physiol. 561, 851–859.
Wall, B.T., Stephens, F.B., Constantin-Teodosiu, D., Marimuthu, K.,
Macdonald, I.A., and Greenhaff, P.L. (2011). Chronic oral ingestion of L-carni-
tine and carbohydrate increases muscle carnitine content and alters muscle
fuel metabolism during exercise in humans. J. Physiol. 589, 963–973.
